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Abstract
Introduction. Blood products, i.e. platelet rich plasma (PRP), leukocyte-poor plasma 
(PRP) and platelet poor plasma (PPP), have previously been used to improve muscle 
regeneration. In this study, six months’ frozen-stored PPP of  individuals who practiced 
different types of  physical exercise was analysed; it could steer mouse C2C12 myoblast 
cells towards proliferation, migration and myogenic differentiation, and it could affect 
the morphology/shape of  myotubes.
Materials and Methods. PPP of  male Olympic weightlifters, football players and 
professional folk dancers, aged 15-19, was collected 12 h post-training and stored for 
6 months at -20°C. C2C12 cell proliferation was assessed by MTT test, motility by 
scratch assay, myogenic differentiation by myotube formation and gelatinase activity by 
gel-zymography.
Results and Conclusions. PPP induced proliferation and migration of  C2C12 cells. 
Proliferative capacity was as follows: weightlifters > dancers > football players; mean 
migratory capacity was: weightlifters = dancers > football players. PPP induced 
formation of  myotubes; significant inter-individual variations were detected: PPP from 
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weightlifters induced formation of  round myotubes, and PPP from football players 
and dancers induced formation of  elongated myotubes. The mean myotube area was 
as follows: football players > dancers > weightlifters. PPP gelatinolytic activity was 
observed; it was negatively correlated with C2C12 myoblast proliferation. These results 
provide general but distinct evidence that PPP of  individuals practicing certain types 
of  exercise can specifically modify myoblast morphology/function. This is significant 
for explaining physiological responses and adaptations to exercise. In conclusion, long-
term, frozen-stored PPP preserves its potential to modify myoblast morphology and 
function. 
Keywords: C2C12 myoblasts, Exercise, Myogenic differentiation, Myotube morphology 
INTRODUCTION
Exercise itself  is a form of  physiological stress known to induce an adaptation response 
(Mooren & Krüger 2015). Specifically, different factors, including growth factors, 
mechanical strain, hypoxia, inflammation and extracellular matrix composition, are 
altered by exercise and strongly influence the cell niches and behaviour of  mesenchymal 
stem cells (MSCs) (Boppart et al., 2015; Diaz et al., 2017).
Besides the traditional approach of  studying stem cells in the context of  embryonic 
development, stem cells are known to play an essential role in regeneration of  
skeletal muscle following exercise-induced muscle damage by responding to tissue 
microenvironment specific signals (Boppart et al., 2015). This fact suggests multipotent 
MSCs as possible powerful therapeutic agents in tissue regeneration. For instance, pre-
clinical studies of  MSC therapy have demonstrated enhanced wound healing (Dantzer 
et al., 2003). Muscular injuries cover one-third of  sports injuries, leading to muscle 
fatigue and pain, and sometimes to injury recurrences (Ekstrand et al., 2011; Woods et 
al., 2004), which are then associated with long absences from training and competition 
(Maffulli et al., 2015). Besides the established approach of  managing sports injuries 
(protection, rest, ice, compression and elevation (PRICE principle), nonsteroidal anti-
inflammatory drugs, physical therapy modalities and corticosteroid injections (Sheth 
et al., 2018), more attention has been recently focused on platelet-derived products.
MSC activities in vivo are known to be regulated by molecular microenvironments. 
Furthermore, structural support, protection and maintenance of  the functional 
integrity of  skeletal muscle are provided through the extracellular matrix, which is 
strongly controlled by matrix metalloproteinase (MMP) activity (de Sousa Neto, 2018). 
Therefore, it is considered that plasma and platelet derived blood fractions could 
enhance tissue repair and regeneration, inducing the release of  signalling factors that 
will create a pro-healing environment at sites of  tissue injury (Rubio-Azpeitia et al., 
2014). Plasma has been extensively studied and used in many different cases to speed 
up wound healing, producing better tissue adherence and homeostasis. Platelet rich 
plasma (PRP) and related blood products, platelet poor plasma (PPP) and leukocyte-
poor PRP, have been used to improve muscle regeneration and repair by enhancing 
differentiation of  skeletal myoblasts. PRP has been viewed as an attractive and safe 
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option, as it enables use of  the patient’s own growth factors and biomolecules to 
augment tissue repair in musculoskeletal injuries (Kon et al., 2011). 
However, to avoid the loss of  platelet bioactivity, some authors suggest injecting 
PRP within 3 h of  preparation (Bausset et al., 2012). According to blood transfusion 
guidelines, the shelf-life of  PPP (with its therapeutic potential preserved) is up to one 
year (Anđelić & Pantelić, 1995). Increased levels of  growth factors were induced by 
stored PPP compared to stored PRP (Bausset et al., 2012), while the effect of  the 
level of  PPP from healthy blood donors on human myogenic differentiation has been 
clarified (Miroshnychenko et al., 2017). Therefore, following on from those studies, 
the aim of  this study was to observe, using mouse C2C12 myoblasts, the difference in 
the capacity of  six months’ frozen-stored PPP from individuals who each practiced 
one of  three different types of  physical exercise to modulate myoblast morphology/
function in vitro. 
MATERIALS AND METHODS
Participants
Competitive Olympic weightlifters (n=6), competitive football players (n=6) and 
professional folk dancers (n=6), all males aged 15-19, participated in the study. This 
research was conducted according to the principles of  the Declaration of  Helsinki and 
in accordance with Good Clinical Practice. All participants, including the parents of  
the minors, were informed of  the purpose of  the study and consented to the research 
protocol and the taking of  blood samples over the course of  this study. Participants 
were free-living, and maintained their usual food intake. They were non-smokers and 
in apparent good health upon clinical examination. None of  the participants reported 
any infectious episodes or any relevant condition, including musculoskeletal injuries, in 
the four weeks preceding the study. All participants had trained regularly for their sport 
in the month before the study. None of  the participants involved in our study were 
using steroidal/non-steroidal anti-inflammatory drugs prior to or during the study.
Platelet Poor Plasma aliquots
Blood was drawn 12 h post-training from the antecubital vein into 9 ml sterile tubes 
containing EDTA (B2 Vacutainer E2E (EDTA), Becton Dickinson, Plymouth, UK). 
Cells were removed from plasma by centrifugation for 20 min, at 3500 rpm, and at 
22°C. Plasma aliquots were stored for 6 months at -20°C.
C2C12 cell viability – proliferation (MTT) assay
Mouse C2C12 myoblast cells (ATCC, Rockville, MD, USA) were grown in DMEM 
cell culture medium (Sigma-Aldrich) supplemented with 10% foetal bovine serum 
(FBS) (PAA Laboratories GmbH, Pasching, Austria) (DMEM-10%FBS). Viability 
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of  C2C12 cells was analysed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) test (Kocić et al, 2103). The cells (5×103 in 100 µL DMEM-10%FBS 
per well) were seeded into 96-well plates and cultivated overnight. The following day 
DMEM/10%FBS was replaced with DMEM medium supplemented with 2% FBS 
(control for the baseline proliferation level) or DMEM supplemented with 2% PPP, 
and the cultivation was continued for 48 h. After this period, 10 µL of  MTT (Sigma-
Aldrich) solution (5 mg/mL in PBS) was added, and after 3 h, the formazan crystals 
were dissolved with 100 µL of  10% SDS containing 10 mM HCl. The absorbance was 
read at 540 nm. Results are presented as a relative viability index, where the viability of  
C2C12 cells grown in DMEM medium supplemented with 2% FBS was set at 100%.
C2C12 motility – scratch assay
The motility of  C2C12 cells was analysed by in vitro scratch assay (Kocić et al, 2103). 
The cells (2.5×104 in 500 µL DMEM-10%FBS per well) were seeded in a 24-well tissue 
culture plate. When the cells reached confluence, a scratch in the monolayer over the 
total diameter of  each well was made using a sterile pipette tip, and cells were further 
cultivated over the next 24 h in DMEM supplemented with 2% PPP. Then, the cells 
were fixed with ice-cold methanol and stained with 0.1% crystal violet. Migration of  
cells into the scratch area was documented by light microscopy and quantified by 
TScratch software (Computational Science and Engineering Laboratory, Swiss Federal 
Institute of  Technology, ETH Zurich, Zurich, Switzerland).
Myogenic differentiation
Myogenic differentiation was confirmed by the test as described in Kocić et al. (2013). 
C2C12 cells (2.5×104 in 500 µL DMEM-10%FBS per well) were seeded in a 24-well 
tissue culture plate. When the cells reached 80% confluence, myogenic differentiation 
was induced with myogenic differentiation medium consisting of  DMEM with 2% 
horse serum (PAA Laboratories GmbH, Pasching, Austria) (positive control) and 
DMEM with 2% PPP. Cultures of  C2C12 cells grown in DMEM-10%FBS were used 
as a negative control. The media were was changed every 48 h, and six days later, 
myogenic differentiation was confirmed based on myotube formation. For every 
participant in this study, up to 30 myotubes were visualized by crystal violet staining 
and documented by light microscopy. The morphometric analysis of  myotubes 
(determination of  length, width and area parameters) was performed with ImageJ 
software (National Institutes of  Health, USA). The myotube sphericity index (SI) is 
the quotient of  the length and width of  a cell.
Osteogenic differentiation
C2C12 cells (2.5×104 in 500 µL DMEM-10%FBS per well) were seeded in a 24-well 
tissue culture plate. When cells reached 80% confluence, osteogenic differentiation 
was induced with osteogenic differentiation medium consisting of  50 μM ascorbic acid 
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(Sigma-Aldrich), 10 nM dexamethasone, 10 mM beta-glycerophosphate (Applichem, 
Darmstadt, Germany), and DMEM-10%FBS (positive control) or DMEM with 2% 
PPP. Cultures of  C2C12 cells grown in DMEM-10%FBS were used as a negative 
control.  The media were changed every 48 h, and six days later, osteogenic 
differentiation was confirmed by ALP activity test as described in Kocić et al. (2013).
Evaluation of relative MMP gelatinase activity in PPP
MMP activity was determined in the blood plasma of  the examined athletes. Plasma was 
exposed to a zymography assay on non-reducing 8% polyacrylamide gels containing 
0.2% gelatine as the MMP substrate. After electrophoretic separation, proteolytic 
activity was revealed by staining gels with Coomassie brilliant blue, and clear degraded 
band areas were quantified by densitometry (Kocić et al, 2103). The MMP activity of  
each sample was normalized to a control serum sample (5% foetal calf  serum), which 
was set as 1 (or 100%). The relative activity of  MMPs in the samples was expressed as 
magnitude of  difference compared to the control.
Statistical analysis
The results are expressed as means ± SD.  Statistically significant differences between 
the groups were determined by Student’s t-test.  Correlation between the analyzed 
parameters was tested by linear regression. Differences with p-values of  <0.05 were 
considered significant. All statistical analyses were carried out in the OriginPro8 
program.
RESULTS
The effect of  PPP from weightlifters (WL), football players (FP) and professional 
folk dancers (FD) on proliferative and migratory characteristics and differentiation 
potential of  mesenchymal stem cells was studied. The C2C12 myoblast cell line, the 
behaviour of  which corresponds to that of  the progenitor lineage, was used as a 
model to study the commitment of  mesenchymal cells to myogenic (of  skeletal muscle 
development) and osteogenic lineages.
Firstly, we analysed if  the soluble factors present in athletes’ plasma fraction with reduced 
platelet count could steer C2C12 cells towards proliferation and migration. The results 
of  the MTT proliferation assay (Figure 1A) showed that all PPP (2% concentration) 
samples analysed in this study induced proliferation of  C2C12 cells, and, among the 
three groups of  athletes, the mean capacities of  PPP to induce proliferation were as 
follows: WL > FD > FP. Additionally, we found the PPP, regardless of  the type of  
athletic activity, induced migration of  C2C12 cells, and the mean induction capacities 
were as follows: WL = FD > FP (Figures 1B and C). Further, cell proliferation and 
motility were positively correlated (p=0.03; r=0.46).
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Figure 1. Platelet poor blood plasma (PPP) of  Olympic weightlifters, professional folk dancers and 
football players modulates proliferation and migration of  myoblast C2C12 cells.
WL: Olympic weight lifters, FD: professional folk dancers and FP: football players. A) Cell proliferation; 
B) Microscopic images of  the stretch motility assay; C) Cell migration. The plots show the mean value 
(■) median (line within box), 25%-75% i.e. interquartile range (box), outliers (whiskers), 1%-99% range 
(), and minimum to maximum range (‒). Horizontal bar indicates a significant difference between 
groups. Proliferation: WL vs FD p=0.001; WL vs FP p=0.001; FD vs FP p=0.004; Migration: WL vs FD 
p=0.8; WL vs FP p=0.007; FD vs FP p=0.03.
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Figure 2. Platelet poor blood plasma (PPP) of  Olympic weightlifters, professional folk dancers and 
football players is a potent inducer of  myogenic differentiation of  myoblast C2C12 cells. 
WL: Olympic weight lifters, FD: professional folk dancers and FP: football players. A) Cell proliferation; 
A) Representative micrographs of  undifferentiated C2C12 cells grown in DMEM-10%FBS cell culture 
medium (a1) and C2C12 cell myotubes induced with DMEM supplemented with 2% horse serum (a2 
and a3). B) Representative micrographs of  C2C12 cells myotubes induced with DMEM supplemented 
with 2% of  athletes’ or dancers’ blood plasma. C) Morphometric characteristics of  myotubes induced 
by blood plasma of: Olympic weight lifters (WL), professional dancers (FD) and football players (FP). 
The plots show the mean value (■) median (line within box), 25%-75% i.e. interquartile range (box), 
outliers (whiskers), 1%-99% range (), and minimum to maximum range (‒). Horizontal bar indicates 
a significant difference between groups. Length: WL vs FD p=0.008; WL vs FP p=0.001; FD vs FP 
p=0.001. Width: WL vs FD p=0.2; WL vs FP p=0.001; FD vs FP p=0.001. Area: WL vs FD p=0.014; 
WL vs FP p=0.001; FD vs FP p=0.001. Sphericity index (SI): WL vs FD p=0.008; WL vs FP p=0.013; 
FD vs FP p=0.7.
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Next, we analysed if  PPP had the capacity to induce myogenic differentiation of  
C2C12 cells. The myogenic differentiation potential of  C2C12 cells was first confirmed 
by formation of  long multinucleated myotubes after six days of  cultivation in the 
myogenic differentiation medium i.e. 2% horse serum (Figure 2A, Table 1). Then, we 
confirmed that all PPP samples analysed induced massive myogenic differentiation 
of  C2C12 cells (Figure 2B). In computer-assisted morphometric analysis, significant 
individual variations in myotube morphometric parameters (area, width, length and 
sphericity index; SI), even between individuals engaged in the same type of  physical 
activity, were detected (Table 1). When myotubes from individuals engaged in different 
types of  physical exercise were compared, their morphology/shape was strongly 
affected by the type of  physical exercise (Figure 2B). Morphometric analysis of  mean 
myotube area for the different groups of  athletes (Figure 2C) showed the following 
increase: WL < FD < FP. Myotubes of  the different groups of  athletes were calculated 
and arranged in order of  decreasing mean SI: WL > FP = FD. These results showed 
that PPP of  FD and FP induced formation of  elongated myotubes compared to PPP 
of  WL.
Table 1. Morphometric parameters of  myotubes induced by platelet-poor blood plasma (PPP) 
of  weightlifters (WL), professional dancers (FD) and football players. 





HS 67 ± 25 549 ± 224 144 ± 47 3.9 ± 2.7
62 499 143  3.2
(30-144) (247-1030) (68-285) (1.3 - 12.6)
WL WL 1 102 ± 49 664 ± 183 165 ± 57 4.0 ± 2.2
94 573 167  3.6
(57-218) (445-978) (80-254) (1.6 - 8.2)
WL 2 70 ± 31 483 ± 176 156 ± 37 2.9 ± 1.2
63 491 162  2.9
 (26-139) (260-876) (80-196) (1.3 - 5.7)
WL 3 56 ± 19 507 ± 152 122 ± 44 4.2 ± 2.5
50 504 125  3.9
 (30-98) (283-777) (60-238) (1.1 - 11.5)
WL 4 65 ± 39 491 ± 152 140 ± 43 3.4 ± 1.6
49 403 148  3.3
 (18-151) (254-828) (58-205) (1.3 - 7.0)
WL 5 48 ± 20 406 ± 83 125 ± 44 3.2 ± 1.2
39 411 122  3.4
 (28-87) (298-544) (74-222) (1.4 - 5.2)
WL 6 78 ± 34 664 ± 216 125 ± 38 5.1 ± 2.2
75 649 118  4.7
  (32-163) (265-1079) (76-209) (1.7 - 10.5)
FD FD 1 82 ± 28 698 ± 161 119 ± 47 6.0 ± 3.1
82 704 119  5.9
 (23-132) (442-1063) (63-209) (2.1 - 13.6)
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cont. Table 1.
FD 2 85 ± 26 640 ± 303 141 ± 52 4.7 ± 3.7
84 570 130  3.2
 (42-141) (285-1095) (76-250) (1.3 - 12.2)
FD3 93 ± 44 798 ± 284 110 ±31 6.9 ± 3.5
82 813 114  6.8
 (24-164) (312-1294) (57-173) (2.6 - 16.6)
FD 4 67 ± 34 506 ± 214 135 ± 41 3.5 ± 1.6
45 423 126  3.7
 (32-133) (234-878) (76-212) (1.5 - 6.6)
FD 5 82 ± 35 653 ± 251 128 ± 40 5.0 ± 2.9
82 630 130  4.1
 (27-144) (267-1229) (57-190) (1.9 - 10.3)
FD 6 75 ± 32 566 ± 185 128 ± 50 4.4 ± 2.1
67 573 125  4.4
  (31-126) (268-911) (63-218) (1.1 - 9.0)
FP FP 1 64 ± 19 497 ± 122 126 ± 40 3.6 ± 2.7
64 499 124  3.7
 (39-94) (248-741) (68-209) (1.2 - 7.4)
FP 2 95 ± 47 650 ± 307 149 ± 49 4.4 ± 2.9
85 583 146  3.8
 (25-212) (289-1214) (69-238) (1.4 - 12.6)
FP 3 76 ± 18 552 ± 145 134 ± 42 4.1 ± 2.5
75 548 142  3.3
 (51-109) (378-883) (78-198) (2.2 - 9.7)
FP 4 62 ± 21 590 ± 172 100 ± 41 6.1 ± 3.7
66 557 92  4.8
 (15-249) (324-1864) (33-193) (1.9 - 15.2)
FP 5 321 ± 119 1024 ± 324 258 ± 90 4.8 ± 1.9
310 1198 249  4.6
 (143-549) (692-2047) (113-481) (1.7 - 9.5)
FP 6 306 ± 112 1364 ± 469 243 ± 89 5.8 ± 3.5
304 1198 229  5.5
 (144-640) (453-2417) (103-426) (1.3 - 17.0)
NOTE: Data for each athlete’s PPP sample are presented as mean ± SD, median and minimum through 
maximum values of  given range. HS: Positive control, 2% horse serum.
As was expected, strong osteogenic differentiation of  C2C12 cells was induced in 
osteogenic differentiation medium. However, for every athlete analysed, 2% PPP in 
the cell culture medium was only a weak inducer of  osteogenic differentiation (Figure 
3). The low capacity to induce osteogenic differentiation was not influenced by the 
type of  physical activity and showed no inter-individual variation within groups of  
athletes.
When blood plasma from athletes executing different types of  physical activity was 
evaluated for total MMP gelatinase activity, no statistically significant difference 
between the groups emerged (Table 2, Figure 4). A negative correlation between cell 
proliferation/viability of  C2C12 myoblasts and gelatinase activity of  PPP was noted.
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Table 2. Relative gelatinase activity of  MMP in platelet-poor blood plasma (PPP) of  Olympic 
weight lifters (WL), folk dancers (FD) and football players (FP)
WL FD FP p# Proliferation* Migration†
MMP 3.7 ± 1.3 3.3 ± 0.6 5.3 ± 1.7 r = -0.50 r = -0.40
activity 3.8 3.2 5.0 >0.05 p = 0.02 p = 0.10
(2.0 – 5.4) (2.7 – 4.4) (3.6 – 8.2)
MMP2 73 ± 9 67 ± 4 75 ± 6
% 73 66 74 >0.05
(60 - 87) (61 - 75) (66 - 84)
MMP9 15 ± 3 17 ± 4 20 ± 9
% 14 19 19 >0.05
(12 - 20) (11 - 23) (9 - 32)
MMP 14 ± 6 15 ± 3 7 ± 3
complexed 9 14 7 >0.05
% (9 - 24) (11 - 20) (2 - 11)
#Significance of  difference in gelatinolytic activity between the groups analysed; *The correlation between 
gelatinolytic activity of  PPP and viability/proliferation of  C2C12 cells; r – correlation coefficient, p 
– probability; †The correlation between gelatinolytic activity of  PPP and migration of  C2C12 cells; r – 
correlation coefficient, p – probability.
Figure 3. Platelet poor blood plasma (PPP) of  Olympic weightlifters, professional folk dancers and 
football players is a weak inducer of  osteogenic differentiation of  myoblast C2C12 cells.
A) negative control: absence of  osteogenic differentiation in the cells grown in DMEM-10% FBS cell 
culture media; B) positive control: strong osteogenic differentiation induced by osteogenic differentiation 
medium; C) weak osteogenic differentiation induced by blood plasma of  examined athletes.
Figure 4. Gelatinolytic activity of  platelet poor blood plasma (PPP) of  Olympic weightlifters, professional 
folk dancers, and football players: Representative zymograms.
C: Control, foetal calf  serum; WL: Olympic weight lifters, FD: professional folk dancers, FP: football 
players.
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DISCUSSION
Despite the increasing popularity of  PRP use for treatment of  muscle injuries, 
conflicting results on the effect of  this biologic on muscle regeneration (Grassi et al, 
2018; Sheth et al., 2018) indicate that modifications in present formulations of  PRP 
are needed (Miroshnychenko et al. 2017). On the other hand, the use of  PPP is more 
convenient as it can be frozen for prolonged times (Miroshnychenko et al., 2017, 
Bausset et al. 2012).
The evidence presented in our research shows that long-term, frozen-stored PPP from 
individuals practicing certain types of  exercise could specifically modify myoblast 
function. Therefore, this frozen plasma retains the capacity to stimulate proliferation, 
migration and myogenic differentiation of  C2C12 myoblasts, which is significant 
for explaining the physiological response and adaptation to exercise. Additionally, 
morphometric analysis showed that myotube morphology/shape was significantly 
affected by the type of  physical exercise. Indicative inter-individual variability in 
myotube area within the exercise groups indicates the potential therapeutic use of  
autologous, long-term, frozen-stored PPP in muscular tissue regeneration. To the best 
of  our knowledge, this study is the first to show the distinct effect of  PPP obtained 
from athletes training in different types of  physical activity on morphology/shape of  
myotubes. 
MSCs express, on various elastic matrices, high basal levels of  myoblast determination 
protein 1 transcription factor on induction by myoblast induction media, and these 
levels are akin to the constitutive expression levels of  C2C12 myoblasts (Engler 
et al., 2006). Additionally, a clear peak for MSCs induced by myoblast induction 
media, showed by Engler et al. (2006), suggest a statistically similar level of  lineage 
commitment for MSCs and C2C12 cells, which justifies the use of  C2C12 myoblasts 
in our study as an ex vivo model of  myogenesis.
A positive effect of  PPP at low concentration (2%) on myogenic differentiation of  
C2C12 myoblasts was observed in our study. Observations provided by Martínez et al. 
(2016) suggest a positive effect of  PPP on bone differentiation of  human periodontal 
ligament stem cells even at low concentrations (2.5%) of  this platelet-derived fraction. 
Recently published results by Miroshnychenko et al. (2017) indicate the in vitro dose 
range of  PPP (i.e. soluble factors of  blood plasma) of  healthy blood donors for 
myogenic differentiation or formation of  multinucleated myotubes is likely between 
1-4%. Miroshnychenko et al. (2017) showed that application of  PPP to cultures 
of  human skeletal muscle myoblast induced myoblast differentiation with visible 
multinucleated myotube formation. Furthermore, the authors noted that only platelet 
removal from PRP and modified-PRP types (i.e., neutrophil-, TGF-β1- or myostatin-
depleted) led to induction of  myoblast differentiation by these preparations at the level 
achieved by the PPP-2% horse serum positive control. Conversely, PRP modification 
with no platelet removal led to increased myoblast proliferation compared to PPP and 
no evidence of  myogenic differentiation.
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The following analysis supports our research data associated with PPP use presented 
in our study. Bausset et al. (2012) evaluated the growth factor-releasing capacity of  
PRP and PPP after 3, 6, and 24 h storage at 20°C. They measured vascular endothelial 
growth factor (VEGF) and platelet-derived growth factor (PDGF-AB) that act mainly 
on mesenchymal stem/stromal cells and play key roles in wound healing.  Mean growth 
factor levels induced by PPP between 3 and 6 h were unchanged but significantly lower 
compared to levels induced by PRP. Conversely, prolonged 24 h storage brought about 
a significantly greater, approximately four-fold, reduction in VEGF release by PRP and 
a significant, approximately five-fold, increase in VEGF levels by PPP. To summarize, 
over an extended (24 h) period, the concentration of  VEGF induced by PRP and 
PPP were 479±82 pg/mL and 281±278, respectively. Furthermore, Matsakas (2018) 
recently presented supporting evidence that platelet factors such as VEGF and PDGF 
could produce positive effects on myoblast proliferation and their commitment to 
differentiation into muscle fibres.
In the current study, we have provided evidence that morphology/shape of  the analysed 
myotubes was influenced by the type of  physical exercise. Recently, for treatment of  
sport-related musculoskeletal conditions, autologous platelet-derived fractions have 
been used as a source of  growth factors, i.e., platelets have been used as therapeutic 
tools (Anitua & Orive, 2012; Wroblewski et al., 2010). Furthermore, clinical reports 
that PRP and related blood products do not show a consistent clinical effect are on the 
rise (Miroshnychenko et al., 2017). There is no standardization, defined concentrations 
or protocols for preparing platelet-derived products (PPP and platelet rich fibrin) from 
PRP, which makes the final products prone to variability. Some authors, to avoid inter-
individual variation in platelet and leukocyte count, use allogeneic pooled platelets for 
preparation of  PRP to potentially acquire more consistent quality (Lange et al., 2007; 
Sonker et al., 2015). By performing morphometric analysis, we showed inter-individual 
variability between myotube parameters within and between the exercise groups. In 
this type of  study, inter-individual variations in morphometric parameters within the 
groups could be due either to variation in residual platelet and leukocyte content and/
or to factors pertaining to each athlete’s status, i.e. hydration status, inflammation, 
circadian rhythms or diet among others (Boswell et al., 2012). Overall, our study 
provides evidence that PPP could be applied as a suitable treatment adjunct for tissue 
regeneration in an autologous manner.
 MMPs participate in the adaptive modifications, remodelling and maintenance 
of  musculoskeletal tissues induced by physical exercise, but elevated concentrations of  
MMPs can create a catabolic environment which can compromise healing (Arnoczky 
et al., 2007; Bramono et al., 2004). Because of  the anabolic versus catabolic potential 
of  PRP, we measured the total relative gelatinase activity/response of  MMP-2 and -9 
in 6 months’ stored PPP obtained from the different groups of  athletes. We found 
that relative gelatinase activity of  MMP was not influenced by the type of  physical 
exercise, yet total relative MMP activity was negatively correlated with C2C12 myoblast 
proliferation. There is evidence that gelatinase determination in serum compared to 
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plasma tends to overestimate enzyme concentrations because of  the release from 
leukocytes and platelets during coagulation (Jung et al., 2001). Conversely, it is not 
clear whether MMP concentrations in various PRP formulations depend on platelet 
count, leukocyte concentration, or both. Also, the enzymatic state, active or inactive, 
of  MMPs in PRP has not been determined (Pifer et al., 2014). Pifer et al. (2014) 
hypothesized that both PRP formulations (low-platelet, low-leukocyte and high-
platelet, high-leukocyte PRP) release MMP-2, -3, and - 9 for several days, and they 
concluded that MMP activity is dependent on platelet count, i.e. higher MMP-2, -3, 
and -9 concentrations in the PRP system was found with higher platelet and leukocyte 
concentrations. Future studies are recommended to clarify the spectrum of  MMP 
activity in different formulations of  PRP, since little is known about their role in PRP 
(or PPP) and how they affect tissue healing. 
 CONCLUSIONS
This study provides the data that platelet poor plasma frozen-stored for six months 
has preserved biological activity that induces myotube formation in vitro. Even more 
interesting is the fact that PPP obtained from three groups of  athletes training in 
different sports has a distinct effect on myogenic differentiation and morphology/
shape of  newly formed myotubes. This strongly suggests sport-dependent specific 
factors should be considered in the future design of  these muscle regeneration 
therapies.
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PLATELET-POOR PLAZMA SPORTISTA KAO POTENCIJALNI 
INDUKTOR MIOGENE DIFERENCIJACIJE C2C12 MIOBLASTA
MASLOVARIĆ S. Irina, ILIĆ Lj. Vesna, STANČIĆ Z. Ana, SANTIBANEZ F. Juan, 
TRIVANOVIĆ I. Drenka, DRVENICA T. Ivana, KRSTIĆ S. Jelena, MOJSILOVIĆ 
B. Slavko, OKIĆ DJORDJEVIĆ N. Ivana, BUGARSKI S. Diana
Kratak sadržaj
Uvod. Krvna plazma obogaćena leukocitima, plazma sa niskim sadržajem leukocita i 
plazma sa niskim sadržajem trombocita (platelet poor plasma; PPP) su produkti krvi 
koji se koriste za stimulaciju regeneracije mišića. U ovom radu smo ispitivali da li zamr-
zavana PPP osoba koje se bave različitim tipovima fizičke aktivnosti, usmerava C2C12 
myoblaste u pravcu povećane proliferacije, migracije i miogene diferencijacije, i da li 
utiče na morfologiju/izgled miotuba.
Materijal i metode. PPP osoba muškog pola starih 15-19 godina je izolovana iz krvi di-
zača tegova, fudbalera i profesionalnih igrača folklora, 12 sati nakon treninga. Uzorci 
PPP su čuvani šest meseci na -20ºC. Uticaj PPP na proliferaciju C2C12 ćelija je analizi-
ran MTT testom, na migraciju „scratch” testom, a uticaj na miogenu diferencijaciju je 
analiziran na osnovu sposobnosti PPP da indukuju formiranje miotuba. Želatinolitička 
aktivnost PPP je analizirana gel-zimografijom.
Rezultati i zaključak. Uzorci PPP su indukovali proliferaciju i migraciju C2C12 ćelija, a 
kapacitet da stimulišu proliferaciju je bio: dizači tegova > igrači > fudbaleri. Kapacitet 
PPP da utiču na migraciju C2C12 ćelija je bio: dizači tegova = igrači > fudbaleri. Svi 
uzorci PPP su indukovali formiranje miotuba, ali su zapažene značajne interindividu-
alne varijacije. PPP dizača tegova su indukovali formiranje okruglih miotuba, dok su 
miotube formirane u prisustvu PPP igrača i fudbalera bile izdužene. Površina miotuba 
se, zavisno od tipa fizičke aktivnosti, menjala po sledećem rasporedu: fudbaleri > igrači 
> dizači tegova. Želatinolitička aktivnost PPP je nagativno korelirala sa proliferacijom 
C2C12 ćelija. Rezultati ove studije pokazuju da PPP osoba koje se bave određenim 
tipom fizičke aktivnosti mogu da na specifičan način modulišu morfologiju/funciju 
mioblasta. Ovaj rezultat je od značaja za objašnjnje fiziološkog odgovora i adaptacije 
na vežbanje. On pokazuje i da PPP nakon dugotrajnog zamrzavanja imaju očuvanu 
spospbnost modifikovanja morfologije i funkcije mioblasta.
Ključne reči: C2C12 mioblasti, fizičko vežbanje, miogena diferencijacija, morfologija 
miotuba
